New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication

Obesity and type 2 diabetes are recognised risk factors for the development of some cancers and, increasingly, predict more aggressive disease, treatment failure, and cancer-specific mortality. Many factors may contribute to this clinical observation. Hyperinsulinaemia, dyslipidaemia, hypoxia, ER st...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunter, Jennifer H., Sarkar, Phoebe L., Lubik, Amy A., Nelson, Colleen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614121/
https://www.ncbi.nlm.nih.gov/pubmed/23573093
http://dx.doi.org/10.1155/2013/834684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614121/
https://www.ncbi.nlm.nih.gov/pubmed/23573093
http://dx.doi.org/10.1155/2013/834684

Ejemplares similares